申请人:Hoechst Aktiengesellschaft
公开号:US05494911A1
公开(公告)日:1996-02-27
Isoxazole-4-carboxamide derivatives and hydroxyalkylidene-cyanoacetamide derivatives are suitable for the treatment of carcinoses. These compounds can be prepared by known processes. Some of the compounds are novel and are additionally suitable for the treatment of rheumatic disorders.
异唑唑酮-4-羧酰胺衍生物和羟基烯基-氰乙酰胺衍生物适用于治疗癌症。这些化合物可以通过已知的方法制备。其中一些化合物是新颖的,此外还适用于治疗风湿性疾病。